$TBRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tobira Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tobira Therapeutics, Inc.. Get notifications about new insider transactions in Tobira Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 04 2016 | TBRA | Tobira Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
Nov 04 2016 | TBRA | Tobira Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Option Exercise | D | 42.93 | 1,071 | 45,978 | 0 | |
Nov 04 2016 | TBRA | Tobira Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Option Exercise | D | 36.00 | 1,996 | 71,856 | 0 | |
Nov 04 2016 | TBRA | Tobira Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Sell | U | 28.35 | 38,094 | 1,079,965 | 0 | 38.1 K to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | DP VI Associates, L.P. | 10% Owner | Sell | U | 28.35 | 1,657 | 46,976 | 0 | 1.7 K to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | U | 28.35 | 3,553,322 | 100,736,679 | 0 | 3.6 M to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | DP VII ASSOCIATES LP | 10% Owner | Sell | U | 28.35 | 47,613 | 1,349,829 | 0 | 47.6 K to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Domain Partners VI, L.P. | 10% Owner | Sell | U | 28.35 | 285,679 | 8,099,000 | 0 | 285.7 K to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Frazier Healthcare V, LP | 10% Owner | Sell | U | 28.35 | 2,668,570 | 75,653,960 | 0 | 2.7 M to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | D | 4.81 | 18,956 | 91,178 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | D | 3.14 | 4,332 | 13,602 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | D | 4.25 | 4,332 | 18,411 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 8.13 | 13,539 | 110,072 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | D | 8.13 | 13,539 | 110,072 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | D | 2.96 | 4,332 | 12,823 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Sell | U | 0.00 | 243,726 | 0 | 0 | 243.7 K to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | D | 2.96 | 4,332 | 12,823 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 42.93 | 535 | 22,968 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 43.83 | 6,111 | 267,845 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 58.23 | 5,666 | 329,931 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Sell | U | 0.00 | 5 | 0 | 0 | 5 to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Sell | U | 0.00 | 11 | 0 | 0 | 11 to 0 (-100.00 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 34.56 | 2,947 | 101,848 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 7.91 | 53,334 | 421,872 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 16.52 | 27,500 | 454,300 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 42.93 | 1,071 | 45,978 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 36.00 | 40,733 | 1,466,388 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 40.59 | 10,253 | 416,169 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 105.21 | 232 | 24,409 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 112.77 | 9,314 | 1,050,340 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | D | 112.77 | 232 | 26,163 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | D | 7.91 | 101,000 | 798,910 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | D | 14.00 | 65,000 | 910,000 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | D | 4.81 | 29,841 | 143,535 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | D | 3.51 | 29,548 | 103,713 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | D | 7.91 | 101,000 | 798,910 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | D | 14.00 | 85,000 | 1,190,000 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | D | 4.81 | 31,091 | 149,548 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | D | 4.81 | 68,732 | 330,601 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | D | 7.91 | 101,000 | 798,910 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | D | 14.00 | 100,000 | 1,400,000 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | D | 3.51 | 79,287 | 278,297 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 7.91 | 258,000 | 2,040,780 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 14.00 | 105,000 | 1,470,000 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 4.81 | 503,882 | 2,423,672 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 4.81 | 83,324 | 400,788 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 3.14 | 16,416 | 51,546 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 3.14 | 53,616 | 168,354 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 3.14 | 4,332 | 13,602 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | D | 2.96 | 4,332 | 12,823 | 0 | |
Nov 02 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 42.10 | 5,000 | 210,500 | 3,758,200 | 3.8 M to 3.8 M (+0.13 %) | |
Nov 02 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 41.71 | 10,000 | 417,100 | 3,753,200 | 3.7 M to 3.8 M (+0.27 %) | |
Oct 19 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 40.04 | 8,300 | 332,332 | 3,743,200 | 3.7 M to 3.7 M (+0.22 %) | |
Oct 19 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 40.10 | 27,400 | 1,098,740 | 3,734,900 | 3.7 M to 3.7 M (+0.74 %) | |
Oct 19 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.89 | 4,300 | 171,527 | 3,707,500 | 3.7 M to 3.7 M (+0.12 %) | |
Oct 06 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.83 | 4,481 | 178,478 | 3,703,200 | 3.7 M to 3.7 M (+0.12 %) | |
Sep 30 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.49 | 9,019 | 356,160 | 3,698,719 | 3.7 M to 3.7 M (+0.24 %) | |
Sep 30 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.49 | 6,500 | 256,685 | 3,689,700 | 3.7 M to 3.7 M (+0.18 %) | |
Sep 28 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.00 | 49,400 | 1,926,600 | 3,683,200 | 3.6 M to 3.7 M (+1.36 %) | |
Sep 28 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.01 | 600 | 23,406 | 3,633,800 | 3.6 M to 3.6 M (+0.02 %) | |
Sep 23 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.09 | 5,000 | 195,450 | 3,633,200 | 3.6 M to 3.6 M (+0.14 %) | |
Sep 23 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | Buy | P | 39.19 | 95,000 | 3,723,050 | 3,628,200 | 3.5 M to 3.6 M (+2.69 %) | |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.45 | 20,000 | 789,000 | 3,533,200 | 3.5 M to 3.5 M (+0.57 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.40 | 27,791 | 1,094,965 | 3,513,200 | 3.5 M to 3.5 M (+0.80 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.30 | 50,000 | 1,965,000 | 3,485,409 | 3.4 M to 3.5 M (+1.46 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.26 | 1,209 | 47,465 | 3,435,409 | 3.4 M to 3.4 M (+0.04 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.14 | 195,000 | 7,632,300 | 3,434,200 | 3.2 M to 3.4 M (+6.02 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 38.97 | 31,000 | 1,208,070 | 3,239,200 | 3.2 M to 3.2 M (+0.97 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.12 | 3,200 | 125,184 | 3,208,200 | 3.2 M to 3.2 M (+0.10 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.07 | 5,000 | 195,350 | 3,205,000 | 3.2 M to 3.2 M (+0.16 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 38.87 | 220,000 | 8,551,400 | 3,200,000 | 3 M to 3.2 M (+7.38 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.23 | 1,000 | 39,230 | 2,980,000 | 3 M to 3 M (+0.03 %) |
Sep 22 2016 | TBRA | Tobira Therapeutic ... | Pentwater Capital Management L ... | 10% Owner | Buy | P | 39.03 | 1,070,000 | 41,762,100 | 2,979,000 | 1.9 M to 3 M (+56.05 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 11.88 | 29,884 | 354,944 | 1,875,905 | 1.9 M to 1.9 M (-1.57 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.12 | 8,752 | 106,072 | 1,905,789 | 1.9 M to 1.9 M (-0.46 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.19 | 20,431 | 249,101 | 1,914,541 | 1.9 M to 1.9 M (-1.06 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.03 | 21,869 | 263,150 | 1,934,972 | 2 M to 1.9 M (-1.12 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.20 | 59,850 | 730,272 | 1,956,841 | 2 M to 2 M (-2.97 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.57 | 10,400 | 130,709 | 2,016,691 | 2 M to 2 M (-0.51 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.58 | 27,133 | 341,368 | 2,027,091 | 2.1 M to 2 M (-1.32 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.63 | 16,068 | 202,947 | 2,054,224 | 2.1 M to 2.1 M (-0.78 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 14.28 | 2,730 | 38,975 | 2,070,292 | 2.1 M to 2.1 M (-0.13 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 13.77 | 20,883 | 287,651 | 2,073,022 | 2.1 M to 2.1 M (-1.00 %) |
Jun 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 10.37 | 187,500 | 1,943,906 | 2,093,905 | 2.3 M to 2.1 M (-8.22 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.54 | 55,000 | 359,667 | 2,281,405 | 2.3 M to 2.3 M (-2.35 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.86 | 25,000 | 171,395 | 2,336,405 | 2.4 M to 2.3 M (-1.06 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.92 | 110,000 | 761,024 | 2,361,405 | 2.5 M to 2.4 M (-4.45 %) |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | A | 7.91 | 101,000 | 798,910 | 101,000 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | A | 7.91 | 101,000 | 798,910 | 101,000 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | A | 7.91 | 101,000 | 798,910 | 101,000 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 7.91 | 258,000 | 2,040,780 | 258,000 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | A | 7.91 | 53,334 | 421,872 | 53,334 | |
Nov 19 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 9.76 | 153,601 | 1,498,685 | 2,471,405 | 2.6 M to 2.5 M (-5.85 %) |
Nov 19 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 9.87 | 71,399 | 704,394 | 2,625,006 | 2.7 M to 2.6 M (-2.65 %) |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | A | 16.52 | 27,500 | 454,300 | 27,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
May 18 2015 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | A | 14.00 | 65,000 | 910,000 | 65,000 | |
May 18 2015 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | A | 14.00 | 85,000 | 1,190,000 | 85,000 | |
May 18 2015 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | A | 14.00 | 100,000 | 1,400,000 | 100,000 | |
May 18 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 14.00 | 105,000 | 1,470,000 | 105,000 | |
May 07 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Option Exercise | A | 2.96 | 4,332 | 12,823 | 4,332 | |
May 07 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Grant | A | 0.00 | 47,613 | 0 | 47,613 | 0 to 47.6 K |
May 07 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Grant | A | 0.00 | 3,553,322 | 0 | 3,553,322 | 0 to 3.6 M |
May 07 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Grant | A | 0.00 | 36,187 | 0 | 36,187 | 0 to 36.2 K |
May 07 2015 | TBRA | Tobira Therapeutic ... | WEBER ECKARD | Director | Grant | A | 0.00 | 243,726 | 0 | 243,726 | 0 to 243.7 K |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 4.81 | 503,882 | 2,423,672 | 672,671 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 4.81 | 83,324 | 400,788 | 168,789 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 3.51 | 6,769 | 23,759 | 85,465 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 3.14 | 16,416 | 51,546 | 78,696 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 3.14 | 53,616 | 168,354 | 62,280 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 3.14 | 4,332 | 13,602 | 8,664 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Fischer Laurent | Chief Executive Off ... | Option Exercise | A | 2.96 | 4,332 | 12,823 | 4,332 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | A | 4.81 | 31,091 | 149,548 | 99,823 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Peetz Christopher | Chief Financial Off ... | Option Exercise | A | 4.81 | 68,732 | 330,601 | 68,732 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 8.13 | 13,539 | 110,072 | 13,539 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | A | 3.51 | 21,607 | 75,841 | 100,894 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | A | 3.51 | 79,287 | 278,297 | 79,287 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | A | 4.81 | 29,841 | 143,535 | 75,700 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | A | 3.51 | 16,311 | 57,252 | 45,859 | |
May 06 2015 | TBRA | Tobira Therapeutic ... | Jenkins Helen | Chief Operating Off ... | Option Exercise | A | 3.51 | 29,548 | 103,713 | 29,548 |